A Study to Evaluate the Efficacy and Safety of Topical Administration of FMX101 in the Treatment of Moderate-to-Severe Acne Vulgaris

NCT03271021 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1488

Enrollment

INDUSTRY

Sponsor class

Conditions

Acne Vulgaris

Interventions

DRUG: FMX101
DRUG: Vehicle Foam

Sponsor

Vyne Therapeutics Inc.